Acetylsalicylic acid Aspirin

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Acetylsalicylic acid Aspirin.php on line 2
Acetylsalicylic acid Aspirin

LE WE PMID CA

Acetylsalicylic acid Aspirin

Acetylsalicylsaeure ASS

Acetylsalicylic acid Aspirin

Cardiovascular risk

Clopidogrel

COX2

FPR2 ALX

Gabapentin

Inflammation resolution

Lipoxin

Maresin

Protectin

Receptor (Lipoxin)

Resolvin

Statin

Thalidomide

2008 1	Salicylate intolerance: pathophysiology, clinical spectrum, diagnosis and treatment. [19633779] Dtsch Arztebl Int 105(8): 137-42 (2008)
2008 2	Pharmacogenetics of aspirin resistance: a comprehensive systematic review. [18429969] Br J Clin Pharmacol 66(2): 222-32 (2008)
2007 3	Aspirin resistance. [18175654] Indian J Physiol Pharmacol 51(2): 109-17 (2007)
2006 4	Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk? [16948802] Aliment Pharmacol Ther 24(6): 897-908 (2006)
2009 5	The present state of aspirin and clopidogrel resistance. [19644597] Hamostaseologie 29(3): 285-90 (2009)
2008 6	[Methods to evaluate aspirin and clopidogrel resistance]. [18278165] Hamostaseologie 28(1-2): 66-71 (2008)
2006 7	[Resistance to acetylsalicylic acid and clopidogrel: current status]. [16906241] Hamostaseologie 26(3): 229-38 (2006)
2003 8	Aspirin resistance: definition, mechanisms and clinical read-outs. [12911581] J Thromb Haemost 1(8): 1710-3 (2003)
2005 9	Narrative review: aspirin resistance and its clinical implications. [15738456] Ann Intern Med 142(5): 370-80 (2005)
2002 10	Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. [11790072] Ann Intern Med 136(2): 161-72 (2002)
2002 11	Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. [11790071] Ann Intern Med 136(2): 157-60 (2002)
2000 12	Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. [10714657] Arch Neurol 57(3): 326-32 (2000)
2000 13	Aspirin. [10715270] Circulation 101(10): 1206-18 (2000)
2008 14	The role of aspirin in cardiovascular prevention: implications of aspirin resistance. [18466797] J Am Coll Cardiol 51(19): 1829-43 (2008)
2010 15	New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin. [20511480] Mayo Clin Proc 85(6): 508-11 (2010)
2010 16	Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. [20508178] Circulation 121(24): 2694-701 (2010)
2010 17	Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. [21071715] Circ Res 107(10): 1170-84 (2010)
2008 18	Aspirin: promise and resistance in the new millennium. [18174450] Arterioscler Thromb Vasc Biol 28(3): s25-32 (2008)
2010 19	Lipoxin and aspirin-triggered lipoxins. [20526535] ScientificWorldJournal 10(-): 1048-64 (2010)
2002 20	Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. [12806051] ScientificWorldJournal 2(-): 169-204 (2002)
2010 21	Therapeutic applicability of anti-inflammatory and proresolving polyunsaturated fatty acid-derived lipid mediators. [20419279] ScientificWorldJournal 10(-): 676-712 (2010)
2007 22	Laboratory detection of 'aspirin resistance': what test should we use (if any)? [17586540] Eur Heart J 28(14): 1673-5 (2007)
2007 23	Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. [17148593] Blood 109(6): 2285-92 (2007)
2007 24	Aspirin and clopidogrel resistance. [18024618] Hematology Am Soc Hematol Educ Program -(-): 114-20 (2007)
2010 25	Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. [20631416] Pharmacol Rep 62(3): 518-25 (2010)
2005 26	Aspirin resistance. [16415485] Pharmacol Rep 57 Suppl(-): 33-41 (2005)
2007 27	Resistance to aspirin and clopidogrel: possible mechanisms, laboratory investigation, and clinical significance. [18196658] Hellenic J Cardiol 48(6): 352-63 (2007)
2011 28	The role of aspirin in women's health. [21792337] Int J Womens Health 3(-): 151-66 (2011)
2010 29	Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin. [21701631] Drug Healthc Patient Saf 2(-): 191-204 (2010)
2011 30	Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis. [21453547] Cardiovasc Diabetol 10(-): 25 (2011)
2009 31	Aspirin resistance in healthy volunteers. [19847061] Clin Hemorheol Microcirc 43(3): 263-4 (2009)
PMC 32	Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies. [23516680] Can J Gastroenterol 27(3):159-67 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Acetylsalicylic acid Aspirin.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Acetylsalicylic acid Aspirin.php on line 92